1. Home
  2. WST vs TROW Comparison

WST vs TROW Comparison

Compare WST & TROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • TROW
  • Stock Information
  • Founded
  • WST 1923
  • TROW 1937
  • Country
  • WST United States
  • TROW United States
  • Employees
  • WST N/A
  • TROW N/A
  • Industry
  • WST Medical/Dental Instruments
  • TROW Investment Bankers/Brokers/Service
  • Sector
  • WST Health Care
  • TROW Finance
  • Exchange
  • WST Nasdaq
  • TROW Nasdaq
  • Market Cap
  • WST 23.2B
  • TROW 26.6B
  • IPO Year
  • WST N/A
  • TROW N/A
  • Fundamental
  • Price
  • WST $315.33
  • TROW $124.18
  • Analyst Decision
  • WST Buy
  • TROW Sell
  • Analyst Count
  • WST 3
  • TROW 12
  • Target Price
  • WST $460.33
  • TROW $114.92
  • AVG Volume (30 Days)
  • WST 551.1K
  • TROW 1.3M
  • Earning Date
  • WST 10-24-2024
  • TROW 11-01-2024
  • Dividend Yield
  • WST 0.26%
  • TROW 4.03%
  • EPS Growth
  • WST N/A
  • TROW 30.16
  • EPS
  • WST 6.74
  • TROW 9.13
  • Revenue
  • WST $2,876,400,000.00
  • TROW $6,911,100,000.00
  • Revenue This Year
  • WST N/A
  • TROW $13.10
  • Revenue Next Year
  • WST $6.22
  • TROW $5.41
  • P/E Ratio
  • WST $47.64
  • TROW $13.47
  • Revenue Growth
  • WST N/A
  • TROW 8.96
  • 52 Week Low
  • WST $265.00
  • TROW $97.50
  • 52 Week High
  • WST $413.70
  • TROW $124.83
  • Technical
  • Relative Strength Index (RSI)
  • WST 52.86
  • TROW 69.82
  • Support Level
  • WST $316.20
  • TROW $121.91
  • Resistance Level
  • WST $326.58
  • TROW $124.83
  • Average True Range (ATR)
  • WST 8.59
  • TROW 1.77
  • MACD
  • WST -0.54
  • TROW 0.11
  • Stochastic Oscillator
  • WST 57.25
  • TROW 98.69

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About TROW T. Rowe Price Group Inc.

T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load us and international stock, hybrid, bond, and money market funds. At the end of August 2024, the firm had $1.612 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a us-based asset manager, deriving less than 10% of its AUM from overseas.

Share on Social Networks: